Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease

被引：21

作者：

Starr, John M. ^{[1
]}

机构：

[1] Univ Edinburgh, Royal Victoria Hosp, Geriatr Med Unit, Edinburgh, Midlothian, Scotland

来源：

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2007年 / 55卷 / 05期

关键词：

D O I：

10.1111/j.1532-5415.2007.01143.x

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：800 / 801

页数：2

共 50 条

[21] Metrifonate for Alzheimer's disease: Is the next cholinesterase inhibitor better?
Sandson, TA
NEUROLOGY, 1999, 52 (03) : 675 - 676
[22] FDA approves new cholinesterase inhibitor for Alzheimer's disease
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (11) : 1026 - +
[23] Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease
Wynn, ZJ
Cummings, JL
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) : 100 - 108
[24] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer’s disease
Linus Jönsson
PharmacoEconomics, 2003, 21 : 1025 - 1037
[25] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease
Jönsson, L
PHARMACOECONOMICS, 2003, 21 (14) : 1025 - 1037
[26] Treatment of advanced Alzheimer's disease with cholinesterase inhibitors
Korczyn, Amos D.
ALZHEIMERS & DEMENTIA, 2008, 4 (05) : 371 - 372
[27] Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly
Vandenberg, CM
Kazmi, Y
Jann, MW
DRUGS & AGING, 2000, 16 (02) : 123 - 138
[28] Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease
Gauthier, Serge
Molinuevo, Jose L.
ALZHEIMERS & DEMENTIA, 2013, 9 (03) : 326 - 331
[29] Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease
Moriearty, PL
Seubert, P
Galasko, D
Markwell, S
Unni, L
Vicari, S
Becker, RE
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (08): : 549 - 554
[30] Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis
Jaime Caro
Denis Getsios
Kristen Migliaccio-Walle
Jack Ishak
Wissam El-Hadi
BMC Geriatrics, 3 (1)

← 1 2 3 4 5 →